Based on the receptor status, out of 110 Breast cancer cases 45 (40.90%) were positive for Her2/neu, 62 (56.37%) were carrying estrogen receptor and 72 (64.45%) were +ve for progesterone receptor. This evidence concerns the gene ESR1 and breast carcinoma.